Ligasan, Sarahme S.
HRN: 23-82-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2023
CEFTRIAXONE 1G (VIAL)
10/01/2023
10/08/2023
IV
400 Mg
Every 12 Hours
AGE With Severe Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes